secwatch.observer — SEC 8-K summary
======================================

Issuer:     electroCore, Inc. (ECOR)
CIK:        0001560258
Form:       8-K
Filed at:   2026-08-06T20:11:27+00:00
Accession:  0001493152-26-036342
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

electroCore Q2 2026 revenue $9.5M (+28% YoY); net loss narrows to $3.1M; raises FY 2026 guidance to >30% growth
--------------------------------------------------------------------------------

- Q2 net sales $9.5M, up 28% YoY from $7.4M; GAAP net loss $3.1M ($0.33/share) vs $3.7M ($0.44) prior year.
- Adjusted EBITDA net loss improved 26% to $1.8M from $2.4M.
- Quell product line sales $1.3M, up ~700% YoY; Truvaga revenue $1.3M, up 27% YoY.
- VA channel: Rx gammaCore revenue up 11% YoY; ~16,400 VA patients (2.7% penetration of addressable headache market).
- Company raises FY 2026 revenue guidance to >30% year-over-year growth; targets positive Adjusted EBITDA in Q3 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560258/000149315226036342/0001493152-26-036342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560258/000149315226036342/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer